Amgen-Novartis migraine collab goes sour

Amgen ’s multibillion-dollar collaboration with Novartis to jointly develop and market Amgen’s migraine-prevention treatment has resulted in both companies filing lawsuits.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news